Carcereny E, Felip E, Reck M, et al. Updated Efficacy Results From the BIRCH Study: First-Line Atezolizumab Therapy in PD-L1–Selected Patients With Advanced NSCLC. 18th World Conference on Lung Cancer (WCLC) 2017, abstract OA 17.02.
Gestage groei aantal patiënten met kanker in Nederland
feb 2017 | Borstkanker, Longoncologie, Maag-darm-leveroncologie